EDGAR Filing Documents for 0001372514-23-000097

Form 8-K - Current report:

SEC Accession No. 0001372514-23-000097

Filing Date

2023-06-06

Accepted

2023-06-06 16:52:21

Documents

Period of Report

2023-06-02

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	kprx-20230602.htm iXBRL	8-K	55847
2	EX-1.1	exhibit11-underwritingagre.htm	EX-1.1	298417
3	EX-3.1	exhibit31-seriesfpreferred.htm	EX-3.1	128613
4	EX-4.3	exhibit43-warrantagencyagr.htm	EX-4.3	136331
5	EX-99.1	exhibit991-pressreleasejun.htm	EX-99.1	10443
6	EX-99.2	exhibit992-closingpressrel.htm	EX-99.2	11401
10	GRAPHIC	image_0.jpg	GRAPHIC	2101
11	GRAPHIC	image_1.jpg	GRAPHIC	241
	Complete submission text file	0001372514-23-000097.txt		913900

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	kprx-20230602.xsd	EX-101.SCH	1917
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	kprx-20230602_lab.xml	EX-101.LAB	25850
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	kprx-20230602_pre.xml	EX-101.PRE	13591
13	EXTRACTED XBRL INSTANCE DOCUMENT	kprx-20230602_htm.xml	XML	12128

Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024

Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869

KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)